Showing 1 - 18 of 18 Results

Notice of Special Interest (NOSI): Social, Behavioral, and Economic Impact of COVID-19 in Underserved and Vulnerable Populations

Notice of Special Interest (NOSI): Preventive Interventions to Address Cardiometabolic Risk Factors in Populations that Experience Health Disparities

Notice of Special Interest (NOSI): Research on the Health of Bisexual and Bisexual+ People

Release Date
Expiration Date
Expiration Date
Activity Code(s)
Organizations
Archived
No

Notice of Special Interest (NOSI): Research on Addressing Violence to Improve Health Outcomes

Notice of Special Interest (NOSI): Increasing Uptake of Evidence-Based Screening in Diverse Populations Across the Lifespan

Notice of Special Interest (NOSI): Firearm Injury and Mortality Prevention Research

Chronic, Non-Communicable Diseases and Disorders Across the Lifespan: Fogarty International Research Training Award (NCD-LIFESPAN) (D43 Clinical Trial Optional)

Release Date
Expiration Date
Expiration Date
Clinical Trials
Organizations
Archived
No

Dissemination and Implementation Research in Health (R01 Clinical Trial Optional)

Release Date
Expiration Date
Expiration Date
Activity Code(s)
Clinical Trials
Archived
No

Dissemination and Implementation Research in Health (R21 Clinical Trial Optional)

Release Date
Expiration Date
Expiration Date
Activity Code(s)
Clinical Trials
Archived
No

STrengthening Research Opportunities for NIH Grants (STRONG): Structured Institutional Needs Assessment and Action Plan Development for Resource Limited Institutions (RLIs) (UC2 - Clinical Trial Not Allowed)

Release Date
Expiration Date
Expiration Date
Activity Code(s)
Clinical Trials
Archived
No

Screening, Brief Intervention and Referral to Treatment or Prevention (SBIRT/P) for alcohol, tobacco, and other drugs (ATOD) use and misuse in adult populations that experience health disparities (R01, Clinical Trial Required)

Release Date
Expiration Date
Expiration Date
Activity Code(s)
Organizations
Archived
No

Multi-sectoral preventive interventions that address social determinants of health in populations that experience health disparities (UG3/UH3, Clinical Trial Required)